OQS
TRML

Occudo Quantitative Strategies’s Tourmaline Bio TRML Stock Holding History

Occudo Quantitative Strategies’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,890
Closed -$87.9K – 1311
2023
Q2 		$87.9K Buy
+2,890
New +$73.8K 0.01% 936

Other funds holding TRML

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Occudo Quantitative Strategies's TRML Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Tourmaline Bio (TRML) in Q3 2023, closing a stake of 2,890 shares — an estimated $87.9K sold.

Occudo Quantitative Strategies first reported a position in TRML in Q2 2023 and held it in 1 quarter. The position peaked at $87.9K in Q2 2023. 48 funds tracked by Wall St. Rank hold TRML as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Tourmaline Bio position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 2,890 Tourmaline Bio shares in Q3 2023, an estimated $87.9K.
  • Occudo Quantitative Strategies first reported a position in Tourmaline Bio in Q2 2023 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Tourmaline Bio position peaked at $87.9K in Q2 2023.
  • 48 funds tracked by Wall St. Rank held Tourmaline Bio as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.